Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

ACELYRIN Inc

SLRN
3,15
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:05:57
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/12/202422:34EDGAR2Form 8-K - Current report
10/12/202422:30GLOBEACELYRIN, INC. Announces Topline Results From Phase 2b/3..
13/11/202423:26EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202422:03EDGAR2Form 8-K - Current report
13/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:00GLOBEACELYRIN, INC. Reports Third Quarter 2024 Financial Results..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
06/11/202422:00GLOBEACELYRIN, INC. to Report Third Quarter 2024 Financial..
04/11/202422:11EDGAR2Form 8-K/A - Current report: [Amend]
16/10/202413:00GLOBEACELYRIN, INC. Forms Scientific and Patient Advisory Board..
19/9/202413:00GLOBEACELYRIN, INC. Announces Positive Results from Global Phase..
10/9/202413:00GLOBEACELYRIN, INC. Announces Positive Proof-of-Concept Data From..
22/8/202413:00GLOBEACELYRIN, INC. to Participate in Upcoming Investor..
13/8/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:14EDGAR2Form 8-K - Current report
13/8/202422:00GLOBEACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep..
06/8/202422:30GLOBEACELYRIN, INC. to Report Second Quarter 2024 Financial..
11/6/202423:05EDGAR2Form 8-K - Current report
05/6/202413:00GLOBEACELYRIN, INC. Announces Positive 16-week Data From its..
29/5/202413:00GLOBEACELYRIN, INC. Announces Lonigutamab Phase 1/2..
28/5/202423:20EDGAR2Form 8-K/A - Current report: [Amend]
25/5/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202401:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202422:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202414:13EDGAR2Form 8-K - Current report
09/5/202414:01GLOBEACELYRIN, INC. Provides Business Update and Highlights Key..
09/5/202414:00GLOBEACELYRIN, INC. Announces Leadership Transition
29/4/202422:05GLOBEACELYRIN, INC. to Report First Quarter 2024 Financial..
28/3/202421:05GLOBEACELYRIN, INC. Reports Full Year 2023 Financial Results and..
27/3/202421:01GLOBEAvalo Acquires Anti-IL-1β mAb and Announces Private..
20/3/202412:00GLOBEACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept..
11/3/202413:05EDGAR2Form 8-K - Current report
11/3/202413:02GLOBEACELYRIN, INC. Announces Positive Top-line Results from Its..
11/3/202413:00GLOBEACELYRIN, INC. Announces Long-term 32-Week Data from the..
15/2/202422:05GLOBEACELYRIN, INC. Appoints Agnes Lee as Senior Vice President,..
12/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/1/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
Apertura: Min: Max:
Chiusura: 3,15

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network